Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-28

Clinical Trial Update: Immunomodulatory Effects of Subcutaneous Progesterone in Patients Affected by Autoimmune Diseases

View source ↗

Summary

A completed clinical trial evaluates the immunomodulatory effects of subcutaneous progesterone in patients with autoimmune diseases and infertility.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Progesterone (subcutaneous) (progesterone)

Snippet

Sponsor: San Carlo Public Hospital, Potenza, Italy | Conditions: Autoimmune Diseases, Infertility | Status: COMPLETED